These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2203523)

  • 1. Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns.
    Ahlert T; Schirrmacher V
    Cancer Res; 1990 Sep; 50(18):5962-8. PubMed ID: 2203523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.
    Schirrmacher V; Haas C; Bonifer R; Ertel C
    Clin Cancer Res; 1997 Jul; 3(7):1135-48. PubMed ID: 9815793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus.
    Fournier P; Zeng J; Von Der Lieth CW; Washburn B; Ahlert T; Schirrmacher V
    Int J Oncol; 2004 Mar; 24(3):623-34. PubMed ID: 14767547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.
    Schirrmacher V; Haas C; Bonifer R; Ahlert T; Gerhards R; Ertel C
    Gene Ther; 1999 Jan; 6(1):63-73. PubMed ID: 10341877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells.
    Termeer CC; Schirrmacher V; Bröcker EB; Becker JC
    Cancer Gene Ther; 2000 Feb; 7(2):316-23. PubMed ID: 10770642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice.
    Ishikawa M; Dennis JW; Man S; Kerbel RS
    Cancer Res; 1988 Feb; 48(3):665-70. PubMed ID: 3335029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque formation of Newcastle disease virus in primary chicken kidney cells.
    Umino Y; Kohama T; Sugiura A
    Behring Inst Mitt; 1991 Jul; (89):59-66. PubMed ID: 1930104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between chicken lymphocytes and Newcastle disease virus.
    Hao Q; Lam KM
    Avian Dis; 1987; 31(3):649-53. PubMed ID: 3675431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application.
    Apostolidis L; Schirrmacher V; Fournier P
    Int J Oncol; 2007 Nov; 31(5):1009-19. PubMed ID: 17912426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.
    Schirrmacher V; Griesbach A; Ahlert T
    Int J Oncol; 2001 May; 18(5):945-52. PubMed ID: 11295039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus.
    Puhlmann J; Puehler F; Mumberg D; Boukamp P; Beier R
    Oncogene; 2010 Apr; 29(15):2205-16. PubMed ID: 20101224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
    Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
    Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of host selective pressure on Newcastle disease virus virulence.
    Zanetti F; Berinstein A; Carrillo E
    Microb Pathog; 2008 Feb; 44(2):135-40. PubMed ID: 17900851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid virus neutralization assay for Newcastle disease virus with the swine testicular continuous cell line.
    Reynolds DL; Maraqa AD
    Avian Dis; 1999; 43(3):564-71. PubMed ID: 10494428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein.
    Bian H; Fournier P; Moormann R; Peeters B; Schirrmacher V
    Int J Oncol; 2005 Feb; 26(2):431-9. PubMed ID: 15645128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of systemic tumor targeting of a viral RNA vector with oncolytic properties using a bispecific adapter protein.
    Bian H; Wilden H; Fournier P; Peeters B; Schirrmacher V
    Int J Oncol; 2006 Dec; 29(6):1359-69. PubMed ID: 17088973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity.
    Walter RJ; Attar BM; Rafiq A; Tejaswi S; Delimata M
    JOP; 2012 Jan; 13(1):45-53. PubMed ID: 22233946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
    Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
    Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.